Trial intelligence / Profile preview

Jinxiang Shugan Pian in mild to moderate depression (liver qi stagnation and spleen deficiency pattern)

CTR20150864Phase 4Completed

Sponsor
Shanghai Shuangji Pharmaceutical
Start
Jan 2016
Countries
1
01

Overview

A Phase 4 trial of Jinxiang Shugan in major depressive disorder (MDD), sponsored by Shanghai Shuangji Pharmaceutical. Started Jan 2016; status: completed.

02

Drugs

Jinxiang Shugan
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on CTR20150864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call